Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PerOs

PerOs
2000 FOUNDED
OOB STATUS
1-10 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Developer of oral bioactive delivery platform designed to brings together a composite of biologically active ingredients that can neutralize the gastric enzymes. The company's bioactive delivery platform has developed non-encapsulation strategies to provide oral administration of bioactive compounds like vaccines, peptides, and antibodies for various animals, such as fish, shrimp, swine, poultry, and companion animals, enabling users control diseases and secure the food safety.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Primary Office
  • 788 Méthot Boulevard
  • Saint-Nicolas, Quebec G7A 3W4
  • Canada

+1 (418) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PerOs’s full profile, request a free trial.

PerOs Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Sep-2011 00.00 Completed Out of Business
2. Corporate (Series C) 10-May-2004 000 00.00 Completed Startup
1. Early Stage VC (Series B) 27-Nov-2002 $1.6M $1.6M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

PerOs Executive Team (4)

Name Title Board
Seat
Contact
Info
Denis Bernier President & Chief Executive Officer

3 Former Executives

You’re viewing 1 of 4 executives. Get the full list »